Larimar Therapeutics CEO Carole Ben-Maimon buys $49,953 in stock.



[
Larimar Therapeutics CEO Carole Ben-Maimon buys $49,953 in stock.
[og_img]
https://www.investing.com/news/insider-trading-news/larimar-therapeutics-ceo-carole-benmaimon-buys-49953-in-stock-93CH-5029351


Investing.com

Latest articles

spot_imgspot_img

Related articles

Leave a reply

Please enter your comment!
Please enter your name here

spot_imgspot_img